121Indexed trials
canonical disease area
Multiple Sclerosis
Intelligence
Multiple Sclerosis intelligence: 121 indexed trials, 28 recruiting studies, 86 sponsors across 62 countries.
28Recruiting
86Sponsors
62Countries
Leading sponsors
Biogen51 recruiting
Hoffmann-La Roche42 recruiting
Teva Neuroscience, Inc.40 recruiting
Celgene40 recruiting
University of Calgary30 recruiting
Cairo University30 recruiting
Tianjin Medical University General Hospital32 recruiting
University Hospital, Basel, Switzerland32 recruiting
Johns Hopkins University20 recruiting
Amgen22 recruiting
Insel Gruppe AG, University Hospital Bern20 recruiting
NYU Langone Health20 recruiting
Geographic activity
United States40trials
Poland14trials
Italy13trials
Canada13trials
Switzerland13trials
Spain12trials
United Kingdom11trials
China10trials
Germany8trials
Belgium8trials
Turkey (Türkiye)8trials
Hungary7trials
Leading interventions
Ocrelizumab6trials
Fingolimod3trials
Inebilizumab2trials
Nabiximols2trials
Standard care2trials
RPC10632trials
Dimethyl Fumarate2trials
Blood Draw2trials
Diroximel Fumarate2trials
All participants will be asked to provide data and samples for collection and analysis.1trials
Azathioprine1trials
Alemtuzumab Injection [Lemtrada]1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.